|
US7173003B2
(en)
|
2001-10-10 |
2007-02-06 |
Neose Technologies, Inc. |
Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF
|
|
US7214660B2
(en)
|
2001-10-10 |
2007-05-08 |
Neose Technologies, Inc. |
Erythropoietin: remodeling and glycoconjugation of erythropoietin
|
|
DK1481057T3
(da)
|
2002-03-07 |
2006-05-15 |
Eidgenoess Tech Hochschule |
System og fremgangsmåde til fremstilling af rekombinante glycosylerede proteiner i en prokaryot vært
|
|
US8791070B2
(en)
|
2003-04-09 |
2014-07-29 |
Novo Nordisk A/S |
Glycopegylated factor IX
|
|
CA2522345A1
(en)
|
2003-04-09 |
2004-11-18 |
Neose Technologies, Inc. |
Glycopegylation methods and proteins/peptides produced by the methods
|
|
WO2005012484A2
(en)
|
2003-07-25 |
2005-02-10 |
Neose Technologies, Inc. |
Antibody-toxin conjugates
|
|
US20080305992A1
(en)
|
2003-11-24 |
2008-12-11 |
Neose Technologies, Inc. |
Glycopegylated erythropoietin
|
|
US8633157B2
(en)
|
2003-11-24 |
2014-01-21 |
Novo Nordisk A/S |
Glycopegylated erythropoietin
|
|
US20060040856A1
(en)
|
2003-12-03 |
2006-02-23 |
Neose Technologies, Inc. |
Glycopegylated factor IX
|
|
NZ548123A
(en)
|
2004-01-08 |
2010-05-28 |
Novo Nordisk As |
O-linked glycosylation of peptides
|
|
US9211248B2
(en)
|
2004-03-03 |
2015-12-15 |
Revance Therapeutics, Inc. |
Compositions and methods for topical application and transdermal delivery of botulinum toxins
|
|
BRPI0508440A
(pt)
|
2004-03-03 |
2007-07-24 |
Revance Therapeutics Inc |
composições e métodos para diagnóstico tópico e transporte terapêutico
|
|
WO2006010143A2
(en)
|
2004-07-13 |
2006-01-26 |
Neose Technologies, Inc. |
Branched peg remodeling and glycosylation of glucagon-like peptide-1 [glp-1]
|
|
EP1814573B1
(en)
|
2004-10-29 |
2016-03-09 |
ratiopharm GmbH |
Remodeling and glycopegylation of fibroblast growth factor (fgf)
|
|
CA2593682C
(en)
|
2005-01-10 |
2016-03-22 |
Neose Technologies, Inc. |
Glycopegylated granulocyte colony stimulating factor
|
|
KR20070110402A
(ko)
*
|
2005-03-03 |
2007-11-16 |
레반스 테라퓨틱스 |
보툴리눔 독소의 국소 적용 및 경피 전달을 위한 조성물 및방법
|
|
US9187546B2
(en)
|
2005-04-08 |
2015-11-17 |
Novo Nordisk A/S |
Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants
|
|
US20080255026A1
(en)
|
2005-05-25 |
2008-10-16 |
Glycopegylated Factor 1X |
Glycopegylated Factor Ix
|
|
US20070105755A1
(en)
|
2005-10-26 |
2007-05-10 |
Neose Technologies, Inc. |
One pot desialylation and glycopegylation of therapeutic peptides
|
|
US20090048440A1
(en)
|
2005-11-03 |
2009-02-19 |
Neose Technologies, Inc. |
Nucleotide Sugar Purification Using Membranes
|
|
CN101516388B
(zh)
|
2006-07-21 |
2012-10-31 |
诺和诺德公司 |
通过o-联糖基化序列的肽的糖基化
|
|
US8969532B2
(en)
|
2006-10-03 |
2015-03-03 |
Novo Nordisk A/S |
Methods for the purification of polypeptide conjugates comprising polyalkylene oxide using hydrophobic interaction chromatography
|
|
EP2144923B1
(en)
|
2007-04-03 |
2013-02-13 |
BioGeneriX AG |
Methods of treatment using glycopegylated g-csf
|
|
WO2008154639A2
(en)
|
2007-06-12 |
2008-12-18 |
Neose Technologies, Inc. |
Improved process for the production of nucleotide sugars
|
|
WO2009089154A2
(en)
|
2008-01-03 |
2009-07-16 |
Cornell Research Foundation, Inc. |
Glycosylated protein expression in prokaryotes
|
|
CN102037004A
(zh)
*
|
2008-01-08 |
2011-04-27 |
生物种属学股份公司 |
使用寡糖基转移酶的多肽的糖缀合
|
|
SI2257307T1
(sl)
*
|
2008-02-20 |
2018-09-28 |
Glaxosmithkline Biologicals S.A. |
Biokonjugati, izdelani iz rekombinantnih N-glikoziliranih proteinov iz prokariontskih celic
|
|
US20130189239A1
(en)
|
2008-02-27 |
2013-07-25 |
Novo Nordisk A/S |
Conjugated Factor VIII Molecules
|
|
CN102365359B
(zh)
*
|
2009-03-27 |
2014-10-29 |
瑞士联邦苏黎世技术大学 |
呈递空肠弯曲杆菌n-聚糖或其衍生物的肠沙门氏菌
|
|
NO2501406T3
(cg-RX-API-DMAC7.html)
*
|
2009-11-19 |
2018-05-19 |
|
|
|
CA2789505C
(en)
|
2010-02-11 |
2017-12-05 |
The Governors Of The University Of Alberta |
N-linked glycan compounds
|
|
WO2011138361A1
(en)
*
|
2010-05-06 |
2011-11-10 |
Glycovaxyn |
Capsular gram-positive bacteria bioconjugate vaccines
|
|
WO2012027850A1
(en)
*
|
2010-09-03 |
2012-03-08 |
Christine Szymanski |
Peptide containing multiple n-linked glycosylation sequons
|
|
CA2847621A1
(en)
|
2011-09-06 |
2013-03-14 |
Glycovaxyn Ag |
Bioconjugate vaccines made in prokaryotic cells
|
|
EP2917351B1
(en)
|
2012-11-07 |
2018-12-19 |
GlaxoSmithKline Biologicals S.A. |
Production of recombinant vaccine in e. coli by enzymatic conjugation
|
|
HUE038915T2
(hu)
|
2013-01-17 |
2018-12-28 |
Arsanis Biosciences Gmbh |
MDR E. colira fajlagos antitest
|
|
US9931392B2
(en)
|
2013-01-18 |
2018-04-03 |
London School Of Hygiene And Tropical Medicine |
Glycosylation method
|
|
GB201301085D0
(en)
|
2013-01-22 |
2013-03-06 |
London School Hygiene & Tropical Medicine |
Glycoconjugate Vaccine
|
|
EP2970128B1
(en)
|
2013-03-15 |
2019-12-04 |
Asieris Pharmaceutical Technologies Co., Ltd. |
Base addition salts of nitroxoline and uses thereof
|
|
CA2907795C
(en)
*
|
2013-04-05 |
2023-09-05 |
The Governors Of The University Of Alberta |
Campylobacter vaccine
|
|
BR112016007727A8
(pt)
*
|
2013-10-11 |
2018-01-30 |
Glycovaxyn Ag |
célula hospedeira, e, método para produzir uma proteína n-glicosilada.
|
|
NZ723328A
(en)
|
2014-02-24 |
2018-01-26 |
Glycovaxyn Ag |
Compositions comprising e. coli o25b antigen, uses thereof and methods of manufacture
|
|
MX378857B
(es)
*
|
2014-04-17 |
2025-03-10 |
Glaxosmithkline Biologicals Sa |
Celulas huespedes modificadas y usos de las mismas.
|
|
AR104469A1
(es)
|
2014-08-08 |
2017-07-26 |
Glycovaxyn Ag |
Células huésped modificadas para su uso en producción de bioconjugados
|
|
SI3240895T1
(sl)
*
|
2014-12-30 |
2022-04-29 |
Glaxosmithkline Biologicals S.A. |
Sestavki in postopki za glikozilacijo proteinov
|
|
TWI715617B
(zh)
|
2015-08-24 |
2021-01-11 |
比利時商葛蘭素史密斯克藍生物品公司 |
對抗腸道外病原性大腸桿菌之免疫保護之方法及組合物
|
|
GB201518668D0
(en)
*
|
2015-10-21 |
2015-12-02 |
Glaxosmithkline Biolog Sa |
Immunogenic Comosition
|
|
WO2017117539A1
(en)
|
2015-12-30 |
2017-07-06 |
Northwestern University |
Cell-free glycoprotein synthesis (cfgps) in prokaryotic cell lysates enriched with components for glycosylation
|
|
GB201610599D0
(en)
|
2016-06-17 |
2016-08-03 |
Glaxosmithkline Biologicals Sa |
Immunogenic Composition
|
|
US10829795B2
(en)
|
2016-07-14 |
2020-11-10 |
Northwestern University |
Method for rapid in vitro synthesis of glycoproteins via recombinant production of N-glycosylated proteins in prokaryotic cell lysates
|
|
AR109621A1
(es)
|
2016-10-24 |
2018-12-26 |
Janssen Pharmaceuticals Inc |
Formulaciones de vacunas contra glucoconjugados de expec
|
|
CN110520153B
(zh)
*
|
2017-01-27 |
2024-04-02 |
佛罗里达大学研究基金公司 |
在禽类中控制肠道沙门氏菌和减少弯曲杆菌的食品安全疫苗
|
|
GB201711635D0
(en)
|
2017-07-19 |
2017-08-30 |
Glaxosmithkline Biologicals Sa |
Immunogenic composition
|
|
GB201712678D0
(en)
|
2017-08-07 |
2017-09-20 |
Glaxosmithkline Biologicals Sa |
Process for the manipulation of nucleic acids
|
|
US11898187B2
(en)
|
2017-08-15 |
2024-02-13 |
Northwestern University |
Protein glycosylation sites by rapid expression and characterization of N-glycosyltransferases
|
|
GB201721582D0
(en)
*
|
2017-12-21 |
2018-02-07 |
Glaxosmithkline Biologicals Sa |
S aureus antigens and immunogenic compositions
|
|
GB201721576D0
(en)
|
2017-12-21 |
2018-02-07 |
Glaxosmithkline Biologicals Sa |
Hla antigens and glycoconjugates thereof
|
|
TW201946650A
(zh)
|
2018-03-12 |
2019-12-16 |
美商詹森藥物公司 |
針對腹內感染之疫苗
|
|
US11530432B2
(en)
|
2018-03-19 |
2022-12-20 |
Northwestern University |
Compositions and methods for rapid in vitro synthesis of bioconjugate vaccines in vitro via production and N-glycosylation of protein carriers in detoxified prokaryotic cell lysates
|
|
WO2019204346A1
(en)
|
2018-04-16 |
2019-10-24 |
Northwestern University |
METHODS FOR CO-ACTIVATING IN VITRO NON-STANDARD AMINO ACID (nsAA) INCORPORATION AND GLYCOSYLATION IN CRUDE CELLLYSATES
|
|
WO2020072127A2
(en)
|
2018-08-03 |
2020-04-09 |
Northwestern University |
On demand, portable, cell-free molecular sensing platform
|
|
JP7551618B2
(ja)
|
2018-12-12 |
2024-09-17 |
グラクソスミスクライン バイオロジカルズ ソシエテ アノニム |
O-結合型グリコシル化のための修飾キャリアタンパク質
|
|
EP3908669A4
(en)
|
2019-01-11 |
2023-05-03 |
Northwestern University |
SYNTHESIS OF BIOCONJUGATED VACCINES IN PROKARYOT CELL LYSATE
|
|
US12325884B2
(en)
|
2019-03-04 |
2025-06-10 |
Northwestern University |
Riboswitch-based fluoride sensing in cell-free extract
|
|
CR20210522A
(es)
|
2019-03-18 |
2021-12-17 |
Janssen Pharmaceuticals Inc |
Bioconjugados de antígenos–polisacáridos de e. coli, métodos de producción y métodos de utilización de los mismos
|
|
IL286467B2
(en)
|
2019-03-18 |
2026-02-01 |
Janssen Pharmaceuticals Inc |
Methods for producing bioconjugates of polysaccharides E. coli o-antigen, preparations thereof and methods for using them
|
|
EP3757217A1
(en)
|
2019-06-27 |
2020-12-30 |
GlaxoSmithKline Biologicals S.A. |
Methods for protein purification
|
|
EP3770269A1
(en)
*
|
2019-07-23 |
2021-01-27 |
GlaxoSmithKline Biologicals S.A. |
Quantification of bioconjugate glycosylation
|
|
EP3777884A1
(en)
|
2019-08-15 |
2021-02-17 |
GlaxoSmithKline Biologicals S.A. |
Immunogenic composition
|
|
US12226410B2
(en)
|
2019-10-18 |
2025-02-18 |
Northwestern University |
Methods for enhancing cellular clearance of pathological molecules via activation of the cellular protein ykt6
|
|
WO2021081485A1
(en)
|
2019-10-25 |
2021-04-29 |
Northwestern University |
Cell-free extract preparation protocol for enrichment of membrane vesicles and increased glycoprotein yields
|
|
MY209568A
(en)
|
2020-01-16 |
2025-07-22 |
Janssen Pharmaceuticals Inc |
Fimh mutant, compositions therewith and use thereof
|
|
CA3185719A1
(en)
|
2020-06-18 |
2021-12-23 |
Glaxosmithkline Biologicals Sa |
Shigella-tetravalent (shigella4v) bioconjugate
|
|
US20230226175A1
(en)
|
2020-06-25 |
2023-07-20 |
Glaxosmithkline Biologicals Sa |
Modified exotoxin a proteins
|
|
PE20231385A1
(es)
|
2020-09-17 |
2023-09-12 |
Janssen Pharmaceuticals Inc |
Composiciones de vacunas multivalentes y usos de las mismas
|
|
CN116888140A
(zh)
|
2021-01-12 |
2023-10-13 |
杨森制药公司 |
FimH突变体、其组合物及其用途
|
|
MX2023011697A
(es)
|
2021-04-01 |
2023-10-19 |
Janssen Pharmaceuticals Inc |
Produccion de bioconjugados o18 de e. coli.
|
|
EP4452308A1
(en)
|
2021-12-22 |
2024-10-30 |
GlaxoSmithKline Biologicals S.A. |
Vaccine
|
|
GB202302579D0
(en)
|
2023-02-23 |
2023-04-12 |
Glaxosmithkline Biologicals Sa |
Immunogenic composition
|
|
KR20260051063A
(ko)
*
|
2023-08-09 |
2026-04-15 |
글락소스미스클라인 바이오로지칼즈 에스.에이. |
변형된 단백질
|
|
KR20260052081A
(ko)
|
2023-08-09 |
2026-04-17 |
글락소스미스클라인 바이오로지칼즈 에스.에이. |
변형된 단백질
|
|
WO2025172892A1
(en)
|
2024-02-16 |
2025-08-21 |
Glaxosmithkline Biologicals Sa |
Modified proteins and methods
|